Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,713 | 4,449 | 5,621 | 3,949 | 3,358 |
| TOTAL | $3,699 | $4,721 | $5,929 | $4,177 | $3,947 |
| Non-Current Assets | |||||
| PPE Net | 343 | 370 | 398 | 426 | 228 |
| TOTAL | $343 | $370 | $398 | $426 | $228 |
| Total Assets | $4,042 | $5,092 | $6,327 | $4,603 | $4,176 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,857 | 718 | 983 | 635 | 726 |
| TOTAL | $1,857 | $718 | $983 | $635 | $726 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,857 | $718 | $983 | $635 | $726 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,805 | 3,802 | 3,140 | 2,896 | 733 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -64,438 | -62,239 | -61,238 | -58,535 | -57,396 |
| TOTAL | $2,185 | $4,374 | $5,343 | $3,968 | $3,450 |
| Total Liabilities And Equity | $4,042 | $5,092 | $6,327 | $4,603 | $4,176 |